|
|
|
|
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc.(NASDAQ:SCMP), today reported top-line results from its phase 2 clinical trial of orally administered cobiprostone for the prevention of...
|
|
|
Vulvar ulcers: Patient characteristics, lesion morphology provide clues for easy diagnosis
Source: Dermatology Times Email|Print| Del.icio.us Digg Reddit Facebook |Save|License 12 Key Points First step is determining if lesion is A true ulcer Aphthae is possibility if the patient is an adolescent or teen little research...
|
|
|
MaRS Innovation selects diabetic wound healing technology as its second commercialization opportunity
See this page online at: http:bioscienceworld.ca/MaRSInnovationselectsdiabeticwoundhealingtechnologyasitssecondcommercializationopportunity Sign up for your free subscription and keep up-to-date.Stay updated on the latest news and...
|
|
|
Baby steps: Laser therapy resolves infantile hemangiomas in many cases
Treating infantile hemangiomas with lasers Avoiding complications from hemangiomas Accessibility of laser therapy for patients with infantile hemangiomas The first cutaneous use for lasers was on vascular lesions in the 1970s.Since that...
|
|
|
Ulcerative colitis: Natural historyan optimistic message from Norway
_ Ulcerative colitis: Natural historyan optimistic message from Norway.
|
|
|
Disseminated histoplasmosis with colonic ulcers in a patient receiving infliximab - Corrected Proof
Langford Lane, Kidlington Oxford.OX5 1GB UK Tel: +44 (0) 1865-843177 (Within Europe) Fax: +44 (0) 1865-843970 E-mail: eurosupport@elsevier.com North American and Rest of World Online Customer Service 6277 Sea Harbor Drive Orlando.
|
|
|
Medical News: Sucampo Reports Top-Line Results Of Phase 2 Clinical Trial Of Cobiprostone For Prevention Of NSA
GastroIntestinal / Gastroenterology News Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials email to a friend printer friendly view / write opinions rate article Current Article Ratings:...
|
|
|
Sucampo Reports Top-Line Results Of Phase 2 Clinical Trial Of Cobiprostone For Prevention Of NSAID-Induced Gas
Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc.(NASDAQ:SCMP), today reported top-line results from its phase 2 clinical trial of orally administered cobiprostone for the prevention of...
|
|
|
POZEN Submits New Drug Application For VIMOVO' (PN 400)
POZEN Inc.(NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO (PN 400), the combination of enteric coated (EC) naproxen and...
|
|
|
POZEN Submits New Drug Application For VIMOVO (PN 400)
POZEN Inc.(NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO (PN 400), the combination of enteric coated (EC) naproxen and...
|
|
|
Differential diagnosis: Histologic features of amelanotic melanoma varied, ambiguous
Histological features of amelanotic melanoma Differential diagnosis Prognosis for amelanotic melanoma New York Amelanotic melanoma varies in its histologic features, and most of these lesions are transected at the base when biopsied,...
|
|
|
Pozen seeks FDA approval for pain drug
NEW YORK-Pozen Inc.said Tuesday it asked the Food and Drug Administration to approve a drug candidate intended to prevent gastric ulcers in patients with chronic pain. Pozen said it filed a New Drug Application with the FDA, and...
|
|
|
BioWorld Today June 30, 2009
Shares of Vectura Group plc rose 8.5 percent on the London stock exchange Monday after the Chippenham, UK-based firm and its partner, Sosei Group Corp., of Tokyo, said Novartis AG had initiated a Phase III study of NVA237, a dry powder...
|
|
|
Melanoma: Findings from Ghent University, Department of Dermatology broaden understanding of melanoma
Findings from Ghent University, Department of Dermatology broaden understanding of melanoma Investigators publish new data in the report 'The role of RhoC in growth and metastatic capacity of melanoma.' 'RhoC overexpression in tumor cells...
|
|
|
FDA panel: eliminate Vicodin, similar drugs
ADELPHI, Md.-Government experts say prescription drugs like Vicodin and Percocet that combine a popular painkiller with stronger narcotics should be eliminated because of their role in deadly overdoses.A Food and Drug Administration panel...
|
|
|
Pozen seeks FDA approval for ulcer drug
Most Popular Links: Pharmacy Jobs | Pharmacy CE | Pharmacy News| Drug Data News| Resources | Computing | Marketplace | Careers | Education | Govt./Legal | PharmacyTech | Business Home| Advertise | Company Info | Contact Us | Free...
|
|
|
Humoral immunity to cows milk proteins and gliadin within the etiology of recurrent aphthous ulcers
_ Humoral immunity to cows milk proteins and gliadin within the etiology of recurrent aphthous ulcers.
|
|
|
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc.(NASDAQ:SCMP), today reported top-line results from its phase 2 clinical trial of orally administered cobiprostone for the prevention of...
|
|
|
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
- Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc.(NASDAQ:SCMP), today reported top-line results from its phase 2 clinical trial of orally administered cobiprostone for the prevention of...
|
|
|
Sucampo Pharma (SCMP) Reports Top-Line Results from Phase 2 Trial of Cobiprostone
Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc.(NASDAQ: SCMP), today reported top-line results from its phase 2 clinical trial of orally administered cobiprostone for the prevention of...
|
|
|
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Companies mentioned in this article: Sucampo Pharmaceuticals, Inc.BETHESDA, Md. -- (BUSINESSWIRE) -- Sucampo Pharma Americas, Inc., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today reported top-line...
|
|
|
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca announced that its development partner, Pozen, Inc., has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for VIMOVO (PN400) (enteric coated naproxen/esomeprazole magnesium) tablets, a product...
|
|
|
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
3652 live jobs on PharmiWeb.com now VIMOVO Proposed as trade name AstraZeneca today announced that its development partner, Pozen, Inc., has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for VIMOVO ...
|
|
|
Contest Offers Young Hockey Enthusiasts the Chance to Play with Fernando Pisani of the Edmonton Oilers
TORONTO, June 29 /CNW/ - This August, children across Canada between the ages of 10 and 12, will have a chance to give back to their communities while lacing up their skates during the Score for Colitis and Crohn's national contest featuring...
|
|
|
Peptic Ulcer Bacterium Alters The Body's Defence System
Helicobacter pylori survives in the body by manipulating important immune system cells.This is shown in a thesis from the Sahlgrenska Academy. The discovery may lead to new treatments against the common peptic ulcer bacterium.
|
